Table 3 Results of Cox regression MACE analysis for different variables, including opium use

Clopidogrel use

0.041 *

Yes

1.362 (1.015–1.828)

0.039 *

1.51 (0.95–2.39)

0.081

Pain to Door time

1 (0.999–1)

0.053 *

0.028 *

1 (1–1)

0.028 *

Calcium channel blocker use

0.368

Yes

1.381 (0.707–2.698)

0.345

Nitrate use

0.138

Yes

1.254 (0.932–1.687)

0.134

HDL

0.993 (0.977–1.009)

0.393

0.389

FBS

1.004 (1.002–1.005)

<0.001*

<0.001*

1 (1–1)

0.025 *

LDL

0.996 (0.992–1.001)

0.132

0.128

Triglyceride

0.999 (0.997–1.001)

0.243

0.215

BMI

0.981 (0.947–1.016)

0.273

0.27

Creatinine

1.203 (1.074–1.349)

0.001 *

0.014 *

1.24 (1.08–1.42)

0.002 *

Hemoglobin

0.837 (0.778–0.901)

<0.001*

<0.001*

0.89 (0.82–0.97)

0.006 *

Statin use

0.21

Yes

1.204 (0.901–1.608)

0.209

COPD

0.677

Yes

0.754 (0.187–3.038)

0.691

Aspirin use

0.09 *

Yes

1.288 (0.96–1.727)

0.092 *

0.76 (0.49–1.18)

0.219

Beta blocker use

0.125

Yes

1.259 (0.94–1.685)

0.122

ACEI/ARB use

0.055 *

Yes

1.328 (0.994–1.773)

0.055 *

0.86 (0.56–1.33)

0.499

Hypertension

0.009 *

Yes

1.485 (1.109–1.987)

0.008 *

1.3 (0.94–1.8)

0.118

DM

0.004 *

Yes

1.553 (1.158–2.083)

0.003 *

1.12 (0.76–1.64)

0.567

Hyperlipidemia

0.917

Yes

0.985 (0.736–1.317)

0.917

Family history of MI

0.198

Yes

0.761 (0.496–1.169)

0.213

IHD

0.002 *

Yes

1.623 (1.207–2.182)

0.001 *

1.47 (1.06–2.04)

0.023 *

Final TIMI2 score

<0.001*

1

0.37 (0.25–0.548)

<0.001*

0.64 (0.4–1.02)

0.059

Gender

0.084 *

Male

0.523 (0.268–1.022)

0.058 *

0.78 (0.38–1.6)

0.499

Age

1.029 (1.016–1.042)

<0.001*

<0.001*

1.02 (1–1.03)

0.014 *

Chronic smoking

0.059 *

Yes

0.713 (0.506–1.003)

0.052 *

0.85 (0.59–1.22)

0.385

Initial TIMI2 score

0.043 *

1

0.79 (0.455–1.372)

0.403

0.79 (0.45–1.39)

0.416

2

0.644 (0.428–0.969)

0.035 *

0.62 (0.41–0.95)

0.027 *

3

0.556 (0.308–1.004)

0.052 *

0.56 (0.31–1.02)

0.058

PCI Result

<0.001*

Unacceptable

3.528 (2.344–5.308)

<0.001*

2.66 (1.63–4.35)

<0.001*

Culprit vessel

0.454

LADnp

0.774 (0.506–1.182)

0.236

non. LAD

0.951 (0.682–1.326)

0.767

IABP

0.034 *

Yes

7.339 (1.82–29.589)

0.005 *

2.75 (0.64–11.83)

0.174

Cardiogenic shock

0.073 *

Yes

12.528 (1.75–89.672)

0.012 *

Door to Device time

0.999 (0.997–1.001)

0.311

0.263

GPIIbIIIa inhibitors use

0.918

Yes

1.017 (0.732–1.414)

0.918

Opium use

0.074 *

Yes

1.314 (0.977–1.767)

0.071 *

1.27 (0.94–1.71)

0.125